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It is necessary to elucidate why in the present coronavirus
disease-19 (COVID-19) global pandemic infection by SARS-
CoV-2 affects children, adults, and elderly people differently.
Epidemiological and clinical data have shown that most
children who test positive for SARS-CoV-2 are either asymp-
tomatic or develop mild symptoms (1-3). Several hypotheses
have been suggested to explain these findings: differences
in the immune system of adults and children (and between
very young children, pre-schooling children, and adolescents);
competition with other respiratory viruses in the respiratory
mucosa and lungs influencing the viral load; and differences
between adults and children in the expression of the ACE2
protein, the SARS-CoV-2 receptor (1). It was recently descri-
bed that the hypomethylation and subsequent hyperexpres-
sion of the ACE2 gene increased susceptibility for developing
COVID-19 (4).
In severe COVID-19 cases, the viral and pulmonary phases
are followed by a final hyperinflammatory phase, which can
lead to severe acute respiratory distress syndrome (ARDS),
often with a fatal outcome. Here, it should be noted that
children are quite susceptible to H1N1-related ARDS (5) and
that the 2003 coronavirus SARS pandemic affected patients
of all ages (6). Therefore, despite the relatively small number
of reported COVID-19 cases in children and the scarce
information on these cases, it is not possible to assume that
all pediatric COVID-19 cases will follow a mild course (7).
The study of the differences between children and adults
with COVID-19 regarding the immune response and disease
course represents a unique opportunity for developing new
therapies (8), which is demanded (9) to avoid the collapse of
health systems now and in the immediate post-pandemic
period (2022-2024), as shown by recent epidemiological
studies (10). Consequently, we decided to investigate the
genomic basis of those differences through a comparative
study of the transcriptional responses of human leukocytes
to SARS-CoV-2 infection in children and adults, also focusing
on the differences between oligosymptomatic and severe
cases, as further described in the following paragraphs.
Severe COVID-19 cases are characterized by a ‘‘cytokine
storm’’ (hypercytokinemia) that promotes hyperinflamma-
tion and ARDS (11,12), which is not observed in oligosymp-
tomatic cases (13). The inflammatory responses in adults and
children vary with age, with a progressive increase in inflam-
matory cytokines and neutrophil activity, which correlates
with the augmented severity of ARDS in elderly people.
Even in pediatric septic shock, the vast majority of genes
with altered expression profiles are in neutrophils (69%) and
monocytes (28%), and just a small minority are in lympho-
cytes (14). Therefore, it is quite probable that in circulating
leukocytes distinct transcriptional modules (see below) are
associated with different responses to SARS-CoV-2 in
COVID-19 patients, thus allowing us to delineate adult and
child responses and, in these two groups, the oligosympto-
matic and severe case subgroups. The functional analysis of
these transcriptional modules will allow, as commented on
below, a better understanding of the pathogenic mechanisms
triggered by SARS-CoV-2 and eventually, the identification
of new therapeutic targets.
The availability of platforms for large scale gene expres-
sion analysis—mainly DNAmicroarrays and next generation
sequencing (NGS)—has made it possible for immune res-
ponse studies to migrate from a reductionist approach to one
of systems biology (15), enabling a global perception of the
molecular, cellular, and tissue events involved in the different
types of immune response (16). Studies at this new global
transcriptome scale have permitted, for instance, a better
understanding of the innate and adaptative immune respon-
ses, of the defense mechanisms against different pathogens,
and the evaluation of the responses to vaccination (17-21).
An initial major hurdle in global transcriptome studies was
how to analyze and interpret the enormously large gene
expression datasets obtained through DNA microarrays or
NGS platforms. The development of statistical and computa-
tional tools for the analysis of gene co-expression networks
helped to overcome this limitation (22,23). These tools are
presently used for associating genes and gene expression
profiles with biological processes and for finding poten-
tial therapeutic targets (24-25). Clustering techniques have
been employed to find genes with similar expression pat-
terns in multiple samples, thus identifying modules (26,27).DOI: 10.6061/clinics/2020/e2078
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Transcriptional modules often represent biological processes
and can be phenotype specific (25). The functional enrich-
ment among the genes within a module is widely used for
disclosing its biological meaning (25). Moreover, it was
found that in gene co-expression networks, the highly con-
nected genes hold the whole transcriptional network together
and are either associated with specific cellular processes or
link different biological processes (23). Connectivity measures
are currently used for the hierarchical categorization of genes
in transcriptional modules highly correlated with at least one
trait of interest (gender, age, disease features, etc.), helping to
find genes that are highly significant for a certain trait or that
link molecular pathways in a cell (25).
The development of mathematical and computational
methods for analyzing modular transcriptional repertoires
has been essential for unraveling the human immune defense
mechanisms associated with good and bad responses to
respiratory viruses (17,28-30). Our group, at the Department
of Pediatrics, FMUSP, has tackled this approach for inves-
tigating the genomic mechanisms associated with the deve-
lopment, maturation, and decline of the immune system in
health and disease (31-33). Recently, studying children under
six months of age hospitalized with acute viral bronchiolitis,
we were able to show that in peripheral blood mononuclear
cells (PBMC) there are distinct transcriptional modules asso-
ciated either with responses to syncytial respiratory virus
(HRSV) or rhinovirus (HRV) (20). We also identified host-
response molecular markers that could be used for etio-
pathogenic diagnosis. The finding of distinct transcriptional
profiles associated with specific host responses to HRSV or
HRV may contribute to unraveling the pathogenic mechan-
isms triggered by different respiratory viruses that are indis-
tinguishable by clinical presentation, paving the way for
new, specific therapeutic strategies.
The experimental approach first adopted for studying the
PBMC response to HRSV and HRV is now being used in our
laboratory to identify the transcriptional responses of human
peripheral blood leukocytes to SARS-CoV-2 following res-
piratory tract infection. Relevant knowledge on this subject
has been newly published. Transcriptome characteristics of
the bronchoalveolar lavage fluid and peripheral PBMC of
COVID-19 patients revealed distinct host inflammatory cyto-
kine profiles and the association between COVID-19 patho-
genesis and excessive cytokine release (34). Compared to
other respiratory viruses, SARS-CoV-2 drives a lower anti-
viral transcriptional response—low IFN-I and IFN-III levels
and elevated chemokine expression—in accordance with the
pro-inflammatory disease state associated with COVID-19
(35). In a complementary line of work, COVID-19 patients
were compared to recovered and healthy subjects through
high dimensional cytometry, and the subsequent integration
of immune and clinical data revealed different immunotypes
related to poor clinical course versus improving health (36).
Returning to our approach, it aims to identify distinctive
transcriptional modules in the response of human leukocytes
to SARS-CoV-2 infection in children and adults, and between
oligosymptomatic and severe cases in both groups. The
transcriptomic data thus obtained—distinctive transcrip-
tional modules and their associated biological functions,
highly connected and high significance genes, etc.—will be
integrated with clinical and demographic data in order to
gain a better understanding of the molecular mechani-
sms involved in the immune response to SARS-CoV-2 and,
eventually, for identifying host-response predictors and
potential therapeutic targets for drugs and vaccines.
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